Howe & Rusling’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-89
Closed -$4K 1054
2015
Q3
$4K Hold
89
﹤0.01% 686
2015
Q2
$5K Hold
89
﹤0.01% 657
2015
Q1
$3K Hold
89
﹤0.01% 720
2014
Q4
$2K Hold
89
﹤0.01% 783
2014
Q3
$2K Hold
89
﹤0.01% 754
2014
Q2
$2K Hold
89
﹤0.01% 715
2014
Q1
$3K Hold
89
﹤0.01% 728
2013
Q4
$2K Buy
89
+85
+2,125% +$2.13K ﹤0.01% 696
2013
Q3
$0 Sell
4
-85
-96% -$1.5K ﹤0.01% 917
2013
Q2
$1K Buy
+89
New +$828 ﹤0.01% 864

Other funds holding PRTA

Howe & Rusling's PRTA Position: Q4 2015 in Review

Howe & Rusling sold out of Prothena Corp (PRTA) in Q4 2015, closing a stake of 89 shares — an estimated $4K sold.

Howe & Rusling first reported a position in PRTA in Q2 2013 and held it in 10 quarters. The position peaked at $5K in Q2 2015. 161 funds tracked by Wall St. Rank hold PRTA as of Q4 2015.

  • Howe & Rusling reported no remaining Prothena Corp position as of Q4 2015 after selling out during the quarter.
  • Howe & Rusling sold 89 Prothena Corp shares in Q4 2015, an estimated $4K.
  • Howe & Rusling first reported a position in Prothena Corp in Q2 2013 and held it in 10 quarters.
  • Howe & Rusling's Prothena Corp position peaked at $5K in Q2 2015.
  • 161 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2015.

Based on Howe & Rusling's 13F filing for Q4 2015, filed 11 Feb 2016.